New Insights Regarding Diagnosis and Medication for Schizophrenia Based on Neuronal Synapse-Microglia Interaction
- PMID: 34063598
- PMCID: PMC8147599
- DOI: 10.3390/jpm11050371
New Insights Regarding Diagnosis and Medication for Schizophrenia Based on Neuronal Synapse-Microglia Interaction
Abstract
Schizophrenia is a common psychiatric disorder that usually develops during adolescence and young adulthood. Since genetic and environmental factors are involved in the disease, the molecular status of the pathology of schizophrenia differs across patients. Recent genetic studies have focused on the association between schizophrenia and the immune system, especially microglia-synapse interactions. Microglia physiologically eliminate unnecessary synapses during the developmental period. The overactivation of synaptic pruning by microglia is involved in the pathology of brain disease. This paper focuses on the synaptic pruning function and its molecular machinery and introduces the hypothesis that excessive synaptic pruning plays a role in the development of schizophrenia. Finally, we suggest a strategy for diagnosis and medication based on modulation of the interaction between microglia and synapses. This review provides updated information on the involvement of the immune system in schizophrenia and proposes novel insights regarding diagnostic and therapeutic strategies for this disease.
Keywords: CX3CR1; complement; diagnosis; medication; microglia; schizophrenia; synaptic pruning.
Conflict of interest statement
The authors declare no competing financial interest.
Figures


Similar articles
-
Developmental expression profiles of axon guidance signaling and the immune system in the marmoset cortex: potential molecular mechanisms of pruning of dendritic spines during primate synapse formation in late infancy and prepuberty (I).Biochem Biophys Res Commun. 2014 Feb 14;444(3):302-6. doi: 10.1016/j.bbrc.2014.01.024. Epub 2014 Jan 30. Biochem Biophys Res Commun. 2014. PMID: 24485715
-
Complement System in Neural Synapse Elimination in Development and Disease.Adv Immunol. 2017;135:53-79. doi: 10.1016/bs.ai.2017.06.004. Epub 2017 Jul 31. Adv Immunol. 2017. PMID: 28826529 Review.
-
Schizophrenia: Complement Cleaning or Killing.Genes (Basel). 2021 Feb 11;12(2):259. doi: 10.3390/genes12020259. Genes (Basel). 2021. PMID: 33670154 Free PMC article. Review.
-
Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning.Nat Neurosci. 2019 Mar;22(3):374-385. doi: 10.1038/s41593-018-0334-7. Epub 2019 Feb 4. Nat Neurosci. 2019. PMID: 30718903 Free PMC article.
-
Microglia Activation and Schizophrenia: Lessons From the Effects of Minocycline on Postnatal Neurogenesis, Neuronal Survival and Synaptic Pruning.Schizophr Bull. 2017 May 1;43(3):493-496. doi: 10.1093/schbul/sbw088. Schizophr Bull. 2017. PMID: 27352782 Free PMC article. Review.
Cited by
-
Microglial contribution to the pathology of neurodevelopmental disorders in humans.Acta Neuropathol. 2023 Nov;146(5):663-683. doi: 10.1007/s00401-023-02629-2. Epub 2023 Sep 1. Acta Neuropathol. 2023. PMID: 37656188 Free PMC article. Review.
-
Gene expression of psychiatric disorder-related kinesin superfamily proteins (Kifs) is potentiated in alternatively activated primary cultured microglia.BMC Res Notes. 2025 Jan 30;18(1):44. doi: 10.1186/s13104-024-07078-y. BMC Res Notes. 2025. PMID: 39885501 Free PMC article.
-
Psychiatric Comorbidities of Inflammatory Bowel Disease: It Is a Matter of Microglia's Gut Feeling.Cells. 2024 Jan 17;13(2):177. doi: 10.3390/cells13020177. Cells. 2024. PMID: 38247868 Free PMC article. Review.
-
Psychoneurobiology Research and Personalized Treatment of Schizophrenia.J Pers Med. 2021 Dec 7;11(12):1319. doi: 10.3390/jpm11121319. J Pers Med. 2021. PMID: 34945791 Free PMC article.
-
DNA methylation status of SHATI/NAT8L promoter in the blood of cigarette smokers.Neuropsychopharmacol Rep. 2023 Dec;43(4):570-575. doi: 10.1002/npr2.12373. Epub 2023 Sep 5. Neuropsychopharmacol Rep. 2023. PMID: 37668111 Free PMC article.
References
-
- Janoutova J., Janackova P., Sery O., Zeman T., Ambroz P., Kovalova M., Varechova K., Hosak L., Jirik V., Janout V. Epidemiology and risk factors of schizophrenia. Neuroendocrinol. Lett. 2016;37:1–8. - PubMed
-
- Devor A., Andreassen O.A., Wang Y., Maki-Marttunen T., Smeland O.B., Fan C.C., Schork A.J., Holland D., Thompson W.K., Witoelar A., et al. Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia. Mol. Psychiatry. 2017;22:792–801. doi: 10.1038/mp.2017.33. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources